These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 17043426

  • 1. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
    Song JS, Seo JJ, Moon HN, Ghim T, Im HJ.
    J Korean Med Sci; 2006 Oct; 21(5):897-903. PubMed ID: 17043426
    [Abstract] [Full Text] [Related]

  • 2. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
    Cheuk DK, Chiang AK, Ha SY, Chan GC.
    Cochrane Database Syst Rev; 2015 May 27; 2015(5):CD009311. PubMed ID: 26017019
    [Abstract] [Full Text] [Related]

  • 3. [Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation].
    Inukai T, Sugita K, Goi K, Akahane K, Hirose K, Nemoto A, Takahashi K, Sato H, Uno K, Furuichi Y, Nakamura M, Miyamoto N, Yamakawa N, Shiraishi K, Kojika S, Tezuka T, Iijima K, Nakazawa S.
    Rinsho Ketsueki; 2004 Apr 27; 45(4):297-303. PubMed ID: 15168445
    [Abstract] [Full Text] [Related]

  • 4. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation.
    Br J Haematol; 2013 Nov 27; 163(4):444-57. PubMed ID: 24102514
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidence and risk factors of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation in adults with prophylactic ursodiol and intravenous heparin or prostaglandin E1.
    Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, Eom KS, Kim YJ, Min CK, Cho SG, Kim DW, Lee JW, Kim HJ, Lee S.
    Bone Marrow Transplant; 2021 Jul 27; 56(7):1603-1613. PubMed ID: 33526915
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
    Haussmann U, Fischer J, Eber S, Scherer F, Seger R, Gungor T.
    Haematologica; 2006 Jun 27; 91(6):795-800. PubMed ID: 16769582
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
    Lakshminarayanan S, Sahdev I, Goyal M, Vlachos A, Atlas M, Lipton JM.
    Pediatr Transplant; 2010 Aug 27; 14(5):618-21. PubMed ID: 20051023
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.